Back
Verve Therapeutics Stock Predictions
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
1
VERV
Verve Therapeutics
Last Price:
6.15
Seasonality Move:
-15.99%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE TradeVerve Therapeutics Stock Forecast
- Over the next 52 weeks, Verve Therapeutics has on average historically fallen by 41.1% based on the past 3 years of stock performance.
- Verve Therapeutics has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
-
Is Verve Therapeutics Stock Undervalued?
The current Verve Therapeutics [VERV] share price is $5.93. The Score for VERV is 1, which is 98% below its historic median score of 50, and infers higher risk than normal. - VERV is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Will Verve Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Verve Therapeutics has on average historically fallen by 41.1% based on the past 3 years of stock performance.
Verve Therapeutics Stock Rating
Sell
1
Verve Therapeutics (VERV)
is a Sell
Is Verve Therapeutics overpriced?
- Verve Therapeutics has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
Verve Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vervetx.com
52-Week Data
52-Week High:
20.12
52-Week Low:
4.31
Prediction Charts
Market Cap:
501.82M
Price in USD:
5.93
Volume:
1.16M
Beta:
1.79
Technical Analysis
SMA50:
5.39
SMA100:
5.62
SMA200:
7.76
52-Wk Change:
-49.53%
Stock Predictions
-
Is Verve Therapeutics stock public?
Yes, Verve Therapeutics is a publicly traded company. -
What is the Verve Therapeutics stock quote today?
The Verve Therapeutics stock price is 5.93 USD today. -
How to buy Verve Therapeutics stock online?
You can buy Verve Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-14 | 4.69 | 5.03 | 5.10 | 4.60 |
| Oct-15 | 5.03 | 5.60 | 5.61 | 4.94 |
| Oct-16 | 5.63 | 5.60 | 5.86 | 5.53 |
| Oct-18 | 5.47 | 5.65 | 5.74 | 5.39 |
| Oct-21 | 5.65 | 5.55 | 5.68 | 5.44 |
| Oct-22 | 5.52 | 5.69 | 5.71 | 5.30 |
| Oct-23 | 5.67 | 5.54 | 5.71 | 5.42 |
| Oct-24 | 5.54 | 5.72 | 6.02 | 5.45 |
| Oct-25 | 5.72 | 5.97 | 6.09 | 5.72 |
| Oct-28 | 6.01 | 5.94 | 6.45 | 5.93 |
| Oct-29 | 5.95 | 6.00 | 6.18 | 5.88 |
| Oct-30 | 5.92 | 5.80 | 6.14 | 5.68 |
| Oct-31 | 5.77 | 5.73 | 5.83 | 5.62 |
| Nov-1 | 5.73 | 5.93 | 5.96 | 5.65 |
Verve Therapeutics Earnings
Verve Therapeutics Earnings Report: Per Share Verve Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Verve Therapeutics Forecast Revenue Growth
Verve Therapeutics Stock Analysis: Historical quarterly revenues per share for Verve Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $0.28 per share.
* Verve Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.